[Rhabdomyolysis in the diabetic state].
Yamada
Satoru
S
Department of Internal Medicine, Kitasato Institute Hospital.
Shimada
Akira
A
Saruta
Takao
T
D000208:Acute Disease; D000818:Animals; D016883:Diabetic Ketoacidosis / Q000150:complications*; D003937:Diagnosis, Differential; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects; D006944:Hyperglycemic Hyperosmolar Nonketotic Coma / Q000150:complications*; D000960:Hypolipidemic Agents / Q000009:adverse effects; D007273:Injections, Intramuscular; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects; D011379:Prognosis; D012206:Rhabdomyolysis / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D014883:Water-Electrolyte Imbalance / Q000150:complications
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D007328:Insulin